# The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome

Study · id `cardio:ct-nct06953778` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06953778](<https://clinicaltrials.gov/study/NCT06953778>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06953778

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 24060 participants.

## Technical summary

Registry record NCT06953778. Randomized; no masking; primary purpose screening. Start 2027-03-08 (anticipated); primary completion 2032-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 24060 participants (planned count; ClinicalTrials.gov record NCT06953778, source copy `cardio:ctgov-nct06953778-2026-06-30`, retrieved 2026-10-26)
- Planned start: 2027-03-08 (anticipated) (ClinicalTrials.gov record NCT06953778, source copy `cardio:ctgov-nct06953778-2026-06-30`, retrieved 2026-10-26)
- Primary completion: 2032-10-01 (anticipated) (ClinicalTrials.gov record NCT06953778, source copy `cardio:ctgov-nct06953778-2026-06-30`, retrieved 2026-10-26)
- Completion: 2033-10-03 (anticipated) (ClinicalTrials.gov record NCT06953778, source copy `cardio:ctgov-nct06953778-2026-06-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06953778, source copy `cardio:ctgov-nct06953778-2026-06-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06953778-2026-06-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome
- Acronym: VALIANT-AF-S
- Condition: Atrial Fibrillation
- Intervention (Device): Zio XT® Patch
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)

## Provenance

Content hash: 48420ccb14429ddac5defbb6e760cfbd1b1e081d179fe172ef2a9effc01afc99
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
